undamentalytics Newsletter
Sign in

Anteris Technologies Global Corp. revenue

Anteris Technologies Global Corp.'s revenue was $1.9m in fiscal 2025, down 29.2% on the year before. Over the last twelve months it was $2.2m.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Dec 20242025Dec 2025LTMJun 2026
Revenue2,7031,9132,242
Growth on the year before—−29.2%—
Gross profit1,2661,3441,681
Gross margin46.8%70.3%75.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
United States $1.6M 84.1% ▼ 9.8%
Germany $272,000 14.2% ▼ 69.8%
Australia $33,000 1.7% ▲ 57.1%
Switzerland $0 0.0% —
SE $0 0.0% —

From Anteris Technologies Global Corp.'s 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Anteris Technologies Global Corp. $2.2m -9.6% —
Femasys Inc $2.3m 21.9% 24.3%
Volitionrx LTD $2.5m 86.3% 68.0%
Seastar Medical Holding Corp $1.7m 123.6% —
Insight Molecular Diagnostics Inc. $1.7m -60.8% 14.9%
Icecure Medical Ltd. $3.4m 2.7% —

Compare with peers

Head to head: AVR vs FEMYAVR vs VNRXAVR vs ICU

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Anteris Technologies Global Corp.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Anteris Technologies Global Corp.